Glyscend Therapeutics Information
Summary
Glyscend Therapeutics is a private company that has been in the industry for 12 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Ashish Nimgaonkar. Its headquarters is located at Baltimore, Maryland, USA. The Glyscend Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $20.5M. To connect with Glyscend Therapeutics employee register on SignalHire.
Organization Website | glyscend.com |
Social Links |  |
Industries | |
Headquarters Location | 600 Suffolk St, Lowell, Massachusetts, 01854 US |
Employees Size | 10-50 employees |
DMA Code | Baltimore Metropolitan Area |
Founded | 2014 |
Operating Status | Independent Company |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Glyscend Therapeutics shows a diverse range of experience levels:
13% for 1–2 years13% for 3–4 years33% for 5–7 years20% for 8–10 years20% have over 11 years of service at Glyscend Therapeutics
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
